Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Corza Health is a healthcare platform company founded in 2019 by Greg Lucier in partnership with GTCR, a prominent private equity firm. Based in San Diego, California, Corza Health focuses on acquiring and integrating healthcare and life sciences companies to create market-leading businesses. The organization emphasizes operational efficiencies and governance to improve financial, operational, and clinical outcomes in the healthcare sector.
Since its inception, Corza Health has pursued a buy-and-build strategy, acquiring companies and assets in the medical technology sector. The firm has successfully established Corza Medical, a surgical technologies platform that includes industry-leading brands such as Quill barbed sutures and TachoSil fibrin sealant patch. The partnership with GTCR provides Corza Health with substantial capital and expertise, enhancing its ability to drive innovation and growth.
Corza Health has made significant strides in the healthcare industry, focusing on transformational investments that yield strong returns. The firm’s commitment to operational excellence and strategic governance has positioned it as a key player in the healthcare investment landscape.
Corza Health employs a multi-faceted investment strategy that targets healthcare and life sciences companies at various stages, including seed, Series A, Series B, and growth equity. The firm seeks to partner with companies that have exceptional management teams and innovative technology solutions tailored to meet customer needs. Corza Health emphasizes the importance of operational efficiencies and governance, providing strategic insights and growth capital to enhance equity value.
The organization is particularly focused on sectors such as healthcare, biotech, and medical devices. Corza Health's investment thesis revolves around building and scaling companies through an acquire-and-build approach, aiming to drive innovation and improve clinical outcomes. The firm actively seeks opportunities to invest in companies that demonstrate potential for significant growth and operational improvement.
Corza Health's portfolio includes three notable companies:
Greg Lucier - Chief Executive Officer. Greg Lucier has over 30 years of leadership experience in the life sciences sector. He previously led Life Technologies, which was acquired by Thermo Fisher for $15.6 billion in 2014. Lucier's expertise in operational management and strategic growth has been instrumental in the formation and success of Corza Health.
To pitch to Corza Health, founders should email info@corzahealth.com. It is important to include a comprehensive overview of the business, including the management team, market opportunity, and how the product or service addresses customer needs. A well-structured pitch deck that highlights operational efficiencies and growth potential is recommended.
Response times may vary, but founders should expect a thorough review process given the firm's focus on operational excellence and governance.
In 2023, Corza Health has continued to focus on its strategy of acquiring and integrating healthcare companies. The firm has highlighted its commitment to driving innovation and improving clinical outcomes through its portfolio. Recent updates indicate ongoing efforts to enhance operational efficiencies within its existing companies.
Corza Health's notable exits include the successful acquisition of CareFusion by Becton Dickinson for over $12 billion, showcasing the firm's ability to transform and scale healthcare businesses.
What are Corza Health's investment criteria?
Corza Health invests in healthcare and life sciences companies with exceptional management teams. The firm focuses on sectors such as healthcare, biotech, and medical devices, targeting companies at seed, Series A, Series B, and growth equity stages.
How can startups apply or pitch to Corza Health?
Startups can reach out to Corza Health via email at info@corzahealth.com. It is advisable to provide a detailed overview of the business model, market potential, and management team in the pitch.
What makes Corza Health different from other investors?
Corza Health differentiates itself through its acquire-and-build strategy, focusing on operational efficiencies and governance to enhance portfolio company value. The firm combines Greg Lucier's extensive operational expertise with GTCR's capital and deal-making capabilities.
What is Corza Health's geographic scope?
Corza Health primarily invests in North America, focusing on healthcare and life sciences companies within this region.
What is the typical check size for investments?
While specific check sizes are not disclosed, Corza Health provides growth capital for transformational investments, indicating a flexible approach to funding based on the needs of the portfolio companies.
What is Corza Health's post-investment involvement?
Corza Health adds value to its portfolio companies through governance, strategic insights, and operational efficiencies, enhancing equity value and driving growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.